AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026)
AbCellera Biologics (ABCL) reported Exchange Rate Effect of -$38000.0 for Q1 2026, down 106.44% on a YoY basis from $590000.0 in Q1 2025, and down 113.1% quarter-over-quarter from $290000.0 in Q4 2025.
AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2026) Analysis & Trends
AbCellera Biologics has reported Exchange Rate Effect for 6 years, with the latest figure at -$38000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 106.44% year-over-year to -$38000.0; the trailing twelve-month figure through Mar 2026 stood at $469000.0 (up 137.64% YoY), and the FY2025 full-year result was $1.1 million, up 141.92% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$38000.0, down from $290000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.1 million in Q4 2023, with the low at -$8.6 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$621647.1 across 5 years, with a median of -$43000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 3841.01% — and 2025, when it surged 1869.77%.
- AbCellera Biologics' Exchange Rate Effect stood at $364000.0 in 2022, then surged by 193.41% to $1.1 million in 2023, then tumbled by 302.25% to -$2.2 million in 2024, then jumped by 113.43% to $290000.0 in 2025, then slumped by 113.1% to -$38000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$38000.0 (Q1 2026), $290000.0 (Q4 2025), and -$544000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | AbCellera Biologics | 1.55 Bn | 1.44 Bn | - | -38,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Sep 30, 2025 | -544,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | -2.16 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | -781,000.00 |
| Mar 31, 2024 | -781,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Dec 31, 2023 | 1.07 Mn |